TMEM30A-DT: A Drug Target / Disease Biomarker (G100506804)

Target Name: TMEM30A-DT

NCBI ID: G100506804

TMEM30A-DT

Other Name(s): TMEM30A divergent transcript

TMEM30A-DT: A Drug Target / Disease Biomarker

TMEM30A-DT is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the transmembrane protein family and is characterized by the presence of a transmembrane region and a cytoplasmic tail. TMEM30A-DT is involved in a number of cellular processes, including cell signaling, neurotransmitter transport, and inflammation.

One of the key functions of TMEM30A-DT is its role in neurotransmitter transport. TMEM30A-DT is involved in the uptake and release of a variety of neurotransmitters, including dopamine, serotonin, and endocannabinoids. These neurotransmitters play important roles in brain function and are involved in a wide range of physiological processes, including mood regulation, pain perception, and motor control.

In addition to its role in neurotransmitter transport, TMEM30A-DT is also involved in cell signaling. It is a signaling molecule that is involved in the regulation of a variety of cellular processes, including cell growth, differentiation, and inflammation. TMEM30A-DT has been shown to play a role in the regulation of stem cell proliferation and the development of cancer.

TMEM30A-DT is also involved in the regulation of inflammation. It is a potent chemoattractant for neutrophils, which are a type of white blood cell that play a key role in fighting off infections. TMEM30A-DT has been shown to play a role in the regulation of neutrophil function and the regulation of inflammatory responses.

In conclusion, TMEM30A-DT is a protein that is involved in a wide range of cellular processes, including neurotransmitter transport, cell signaling, and inflammation. Its functions as a drug target or biomarker make it an attractive target for researchers to study and potentially develop new treatments for a variety of diseases. Further research is needed to fully understand the role of TMEM30A-DT in these processes and to develop effective treatments.

Protein Name: TMEM30A Divergent Transcript

The "TMEM30A-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM30A-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets